Healthy volunteers help test new Drug's safety
NCT ID NCT05232175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety and tolerability of a drug called ALT-BB4 in 290 healthy adults. Researchers monitored for allergic reactions and other side effects. The goal was to gather safety information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH, SUBJECTIVE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Drug interaction study reveals how itraconazole and rifampin alter HMPL-453 levels
- Essential oil pills: do capsules change how they work?
- Scientists investigate body Fats' role in breast cancer and weight
- Mindfulness program aims to ease stress for head start teachers
- New drug SIM0811 put to the test in healthy volunteers
- Can cleaning up streets and filling tax forms boost health? philly study aims to find out